<- Go Home
Mayne Pharma Group Limited
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Market Cap
AUD 216.1M
Volume
563.4K
Cash and Equivalents
AUD 67.3M
EBITDA
AUD 26.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 255.0M
Profit Margin
62.63%
52 Week High
AUD 6.50
52 Week Low
AUD 2.04
Dividend
N/A
Price / Book Value
0.61
Price / Earnings
-2.56
Price / Tangible Book Value
-1.47
Enterprise Value
AUD 191.1M
Enterprise Value / EBITDA
6.32
Operating Income
-AUD 38.2M
Return on Equity
20.58%
Return on Assets
-2.30
Cash and Short Term Investments
AUD 67.4M
Debt
AUD 42.5M
Equity
AUD 352.7M
Revenue
AUD 407.1M
Unlevered FCF
AUD 6.0M
Sector
Pharmaceuticals
Category
N/A